Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2012
05/16/2012EP2275430B1 Hemifumarate of a pyrazole derivative
05/16/2012EP2224945B1 Methods of enhancing diabetes resolution
05/16/2012EP2183247B1 New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl]1h- indole- 5 -carbonitrile citrate
05/16/2012EP2144902B1 [6,6]and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
05/16/2012EP1480993B2 Desaturase genes, enzymes encoded thereby, and uses thereof
05/16/2012CN102460175A STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR a-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR a-CHAIN
05/16/2012CN102459599A Nucleic acid modulators of glycoprotein vi
05/16/2012CN102459598A Targeting micrornas for metabolic disorders
05/16/2012CN102459594A Use of inhibitors of zdhhc2 activity for modulation of adipogenesis
05/16/2012CN102459312A Melanocortin receptor-specific peptides
05/16/2012CN102459311A 神经调节肽u衍生物 Neuromedin derivative u
05/16/2012CN102459279A 治疗剂713 Therapeutic agent 713
05/16/2012CN102459252A 用于治疗糖原合酶激酶3相关疾病诸如阿尔茨海默病的咪唑取代的嘧啶 For the treatment of glycogen synthase kinase 3-related diseases such as Alzheimer's disease pyrimidine substituted imidazole
05/16/2012CN102459247A 作为醛固酮合酶抑制剂的苯并噁唑酮衍生物 As aldosterone synthase inhibitors benzoxazole derivatives
05/16/2012CN102459229A 用作食欲肽拮抗剂的3-氮杂二环[4.1.0]庚烷 Orexin antagonists used azabicyclo [4.1.0] heptane
05/16/2012CN102459227A Ccr2的4-氮杂环丁烷基-1-苯基-环己烷拮抗剂 Ccr2 4-azetidinyl-1-phenyl - cyclohexane antagonist
05/16/2012CN102459226A Ccr2的4-氮杂环丁烷基-1-杂原子连接的-环己烷拮抗剂 Ccr2 4-azetidinyl -1- heteroatom attached - cyclohexane antagonist
05/16/2012CN102459225A Ccr2的4-氮杂环丁烷基-1-杂芳基-环己烷拮抗剂 Ccr2 4-azetidinyl -1- heteroaryl - cyclohexane antagonist
05/16/2012CN102459222A 用作gpr119 调节剂的l-(哌啶-4-基)-吡唑衍生物 Used gpr119 modulators l- (piperidin-4-yl) - pyrazole derivatives
05/16/2012CN102459221A 噻吩衍生物 Thiophene derivative
05/16/2012CN102459217A 影响血糖指数的化合物 Compounds on the glycemic index
05/16/2012CN102459215A 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
05/16/2012CN102459200A 适用于治疗响应于调节血清素5-ht6受体的疾病的苯磺酰基苯胺化合物 Applicable to the treatment response to serotonin 5-ht6 regulating receptor diseases Phenylsulfonylaniline compound
05/16/2012CN102459199A 适于治疗响应于5-羟色胺5-HT<sub>6</sub>受体调节的病症的苯磺酰苯胺化合物 Adapted to therapeutic response to serotonin 5-HT <sub> 6 </ sub> receptor modulated disorder benzenesulfonyl aniline compound
05/16/2012CN102459198A Crystals
05/16/2012CN102459196A 用于制备罗苏伐他汀的新方法，可用于制备罗苏伐他汀的中间体化合物，以及用于制备所述中间体化合物的方法 A new method for the preparation of rosuvastatin, rosuvastatin preparing intermediate compounds, and methods for preparing the intermediate compounds may be used
05/16/2012CN102459185A 新型甲状腺激素β受体激动剂 Novel thyroid hormone receptor β agonists
05/16/2012CN102459175A 用于治疗糖尿病的哌啶衍生物 For treating diabetes piperidine derivative
05/16/2012CN102459170A Crystal forms of saxagliptin
05/16/2012CN102459162A 新型环戊烷衍生物 The new derivatives of cyclopentane
05/16/2012CN102459158A 新的酰胺和脒衍生物和其用途 Novel amide and amidine derivatives and use thereof
05/16/2012CN102459142A Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
05/16/2012CN102458579A 吡嗪并氧氮杂*衍生物 Pyrazino oxazepin * Derivatives
05/16/2012CN102458472A Pharmaceutical composition, food or beverage, and methods for these products
05/16/2012CN102458428A Nfat signal inhibitor and calcineurin inhibitor
05/16/2012CN102458415A Bifidobacteria for treating diabetes and related conditions
05/16/2012CN102458390A Combination of leucine source and omega-3 unsaturated fatty acid source for prophylactic or therapeutic treatment of hypercalcaemia
05/16/2012CN102453095A Fusion protein containing GLP (glucagon-like peptide)-1 and preparation method and application thereof
05/16/2012CN102453094A Fusion protein containing Exendin-4 and preparation method and application thereof
05/16/2012CN102453026A C-aryl glucoside derivative, preparation method and application thereof
05/16/2012CN102453001A Sulfomorpholine compounds, preparation method thereof and purpose thereof
05/16/2012CN102451472A Application of minimal heterodimer partner in blood lipid regulation
05/16/2012CN102451465A Use of SIRT1 in preparation of drugs for prevention of diseases caused by endothelial dysfunction
05/16/2012CN102451464A Bile acid combining agent, serum cholesterase amount reduction agent and method for reducing serum cholesterase amount
05/16/2012CN102451363A Chinese herbal medicinal weight-reducing tea
05/16/2012CN102451357A Chinese medicine for treating diabetes
05/16/2012CN102451346A Medicinal liquor for diminishing inflammation, and preparation method thereof
05/16/2012CN102451336A Preparation method of bovine pancreas powder serving as medicament for treating diabetes
05/16/2012CN102451333A Method of extracting water-soluble saponin from yellow ginger
05/16/2012CN102451284A Method for preparing prepared rhizoma rehmanniae slices
05/16/2012CN102451251A Method for preparing effective hypoglycemic parts of quince fruits and application of effective hypoglycemic parts
05/16/2012CN102451248A Application of traditional Chinese medicine composition in preparation of medicament for treating diabetic neuropathy
05/16/2012CN102451219A Fermented soya bean active substance and preparation method thereof
05/16/2012CN102451215A Extraction technology of gypenoside
05/16/2012CN102451201A Extraction process for ginkgo leaf extract for injection
05/16/2012CN102451197A Active Chinese medicine prescription for preventing and treating diabetes and preparation process thereof
05/16/2012CN102451192A Blood sugar reducing capsules using abalone maw as main component, and preparation method thereof
05/16/2012CN102451188A High-energy nutrient infusion solution and preparation method thereof
05/16/2012CN102451187A High-energy nutrient infusion solution and preparation method thereof
05/16/2012CN102451185A Metal ion nanocluster composition
05/16/2012CN102451179A Enteric solid preparation containing lycopene, resveratrol or melatonin and preparation method of enteric solid preparation
05/16/2012CN102451178A Application of dihydrofuran-2-ketone compounds in preparing medicament for resisting diabetes mellitus and glucose and lipid metabolism
05/16/2012CN102451161A Dispersible tablets containing cholesterol absorption inhibitor and lipid regulating drug, and application thereof
05/16/2012CN102451092A Effervescent bath salt block and preparation method thereof
05/16/2012CN102450718A Pulse sports beverage and preparation method thereof
05/16/2012CN101732292B Novel application of tetrahydrocurcumin
05/16/2012CN101522220B Long-term enteral feed for maintenance
05/16/2012CN101461896B Chinese medicinal composition assistant for reducing blood fat and preparation method thereof
05/16/2012CN101386594B 1,2,4,5-tetrahydro-3H-benzazepine derivatives, process for their preparation and pharmaceutical compositions containing them
05/16/2012CN101282936B Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
05/16/2012CN101228127B Novel piperidine derivative
05/16/2012CN101137368B Roflumilast for the treatment of diabetes mellitus
05/15/2012US8178713 Sulfur-containing phospholipid derivatives
05/15/2012US8178693 N3 alkylated benzimidazole derivatives as MEK inhibitors
05/15/2012US8178651 Somatostatin-dopamine chimeric analogs
05/15/2012US8178553 Compounds for the treatment of inflammatory disorders
05/15/2012US8178541 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
05/15/2012US8178518 Mixture of androgen, macrocyclic ketone enhancer and thickener; glandular disorders
05/15/2012US8178115 Method and composition for the treatment of scars
05/15/2012CA2694480C Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
05/15/2012CA2670703C Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
05/15/2012CA2614775C Compositions from buckwheat for management of diabetes
05/15/2012CA2572631C A crystalline variable hydrate of (s)-(3-pyridinecarboxamide,6-[4-[2-[[3-(9h-carbazol-4-yloxy)-2-hydroxypropyl]amino]-2-methylpropyl]phenoxy]- hemi-succinate salt
05/15/2012CA2526361C Amide derivative
05/15/2012CA2517435C Hydroxypropylated starch for the treatment or prevention of obesity or diabetes
05/15/2012CA2496329C Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
05/15/2012CA2478553C Probiotic delivery system
05/15/2012CA2474964C An insulin improving agent containing adiponectin
05/15/2012CA2463569C Activator for peroxisome proliferator-activated receptor .delta.
05/15/2012CA2449139C Acid controlled induced viscosity fiber system and uses thereof
05/15/2012CA2449053C Dual viscosity fiber system and uses thereof
05/15/2012CA2448933C A retinoic acid metabolizing cytochrome p450
05/15/2012CA2434237C Glp-1 fusion proteins
05/15/2012CA2430978C Vla-4 inhibitors
05/15/2012CA2378243C Methods for treating or preventing pain and anxiety
05/15/2012CA2283642C Therapeutic compositions
05/10/2012WO2012061708A1 Crystalline forms of hydrochloride salt of (4a-r,9a-s) -1- (1h - benzoimidazole- 5 -carbonyl) -2, 3, 4, 4a, 9, 9a - hexahydro -1h- indeno [2, 1 -b] pyridine- 6 -carbonitrile and their use as hsd 1 inhibitors
05/10/2012WO2012061597A1 Alpha-glucosidase binders and methods of their use
05/10/2012WO2012061466A2 Methods for treating steatotic disease
05/10/2012WO2012060718A1 Preventing or treating metabolic syndrome by administering a trans fatty acid, or a salt, ester or precursor thereof, or sialic acid in free or bound form
1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 1298